Found: 279
Select item for more details and to access through your institution.
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2621, doi. 10.1007/s13555-024-01242-9
- By:
- Publication type:
- Article
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2523, doi. 10.1007/s13555-024-01238-5
- By:
- Publication type:
- Article
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 451, doi. 10.1007/s40801-024-00439-w
- By:
- Publication type:
- Article
Silicon membranes for extracorporeal life support: a comparison of design and fabrication methodologies.
- Published in:
- Biomedical Microdevices, 2023, v. 25, n. 1, p. 1, doi. 10.1007/s10544-022-00639-7
- By:
- Publication type:
- Article
Comparing outcomes of venovenous versus venoarterial extracorporeal membrane oxygenation in neonatal and pediatric respiratory failure: A retrospective review of Extracorporeal Life Support Organization registry.
- Published in:
- Journal of Pediatric Critical Care, 2023, v. 10, n. 5, p. 205, doi. 10.4103/jpcc.jpcc_65_23
- By:
- Publication type:
- Article
Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
USING BEST-WORST SCALING IN HORIZON SCANNING FOR HEPATOCELLULAR CARCINOMA TECHNOLOGIES.
- Published in:
- International Journal of Technology Assessment in Health Care, 2012, v. 28, n. 3, p. 339, doi. 10.1017/S026646231200027X
- By:
- Publication type:
- Article
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.
- Published in:
- Rheumatology, 2014, v. 53, n. 2, p. 332, doi. 10.1093/rheumatology/ket351
- By:
- Publication type:
- Article
Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab.
- Published in:
- International Journal of Dermatology, 2024, v. 63, n. 4, p. 534, doi. 10.1111/ijd.17055
- By:
- Publication type:
- Article
Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 3, p. 185, doi. 10.1007/s40261-022-01240-9
- By:
- Publication type:
- Article
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 517, doi. 10.2147/PPA.S233993
- By:
- Publication type:
- Article
Burden of trachoma in five counties of Eastern Equatoria state, South Sudan: Results from population-based surveys.
- Published in:
- PLoS Neglected Tropical Diseases, 2017, v. 11, n. 6, p. 1, doi. 10.1371/journal.pntd.0005658
- By:
- Publication type:
- Article
Cestode infection in 2 dogs: cytologic findings in liver and a mesenteric lymph node.
- Published in:
- Veterinary Clinical Pathology, 2013, v. 42, n. 1, p. 103, doi. 10.1111/vcp.12016
- By:
- Publication type:
- Article
What is your diagnosis? Urine sediment from a southern California cat with weight loss.
- Published in:
- Veterinary Clinical Pathology, 2010, v. 39, n. 4, p. 517, doi. 10.1111/j.1939-165X.2010.00272.x
- By:
- Publication type:
- Article
Space-occupying Lesion Within the Calvarium of a Cat.
- Published in:
- Veterinary Clinical Pathology, 2002, v. 31, n. 1, p. 19, doi. 10.1111/j.1939-165X.2002.tb00272.x
- By:
- Publication type:
- Article
Cytologic Evaluation of Inflammation in Canine Liver Aspirates.
- Published in:
- Veterinary Clinical Pathology, 2001, v. 30, n. 4, p. 193, doi. 10.1111/j.1939-165X.2001.tb00431.x
- By:
- Publication type:
- Article
Flow Cytometric Evaluation of Canine Bone Marrow Differential Cell Counts.
- Published in:
- Veterinary Clinical Pathology, 2000, v. 29, n. 3, p. 97, doi. 10.1111/j.1939-165X.2000.tb00412.x
- By:
- Publication type:
- Article
Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years.
- Published in:
- Allergy, 2024, v. 79, n. 6, p. 1560, doi. 10.1111/all.16108
- By:
- Publication type:
- Article
Correction to: From idea to systems solution: enhancing access to primary care in Malawi.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Shift Symmetries and AdS/CFT.
- Published in:
- Journal of High Energy Physics, 2023, v. 2023, n. 7, p. 1, doi. 10.1007/JHEP07(2023)103
- By:
- Publication type:
- Article
Adaptive management of large‐scale ecosystem restoration: increasing certainty of habitat outcomes in the Columbia River Estuary, U.S.A.
- Published in:
- Restoration Ecology, 2022, v. 30, n. 8, p. 1, doi. 10.1111/rec.13634
- By:
- Publication type:
- Article
Using landscape ecology principles to prioritize habitat restoration projects across the Columbia River Estuary.
- Published in:
- Restoration Ecology, 2022, v. 30, n. 3, p. 1, doi. 10.1111/rec.13519
- By:
- Publication type:
- Article
Resident Education: Effect of the Sixth National Psoriasis Foundation Chief Residents' Meeting.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2006, v. 10, n. 1, p. 16, doi. 10.1007/7140.2006.00009
- By:
- Publication type:
- Article
Bimekizumab for the Treatment of Psoriasis.
- Published in:
- Drugs, 2021, v. 81, n. 15, p. 1751, doi. 10.1007/s40265-021-01612-z
- By:
- Publication type:
- Article
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”.
- Published in:
- Drugs, 2018, v. 78, n. 8, p. 853, doi. 10.1007/s40265-018-0919-1
- By:
- Publication type:
- Article
Recess is Time-in: Using Peers to Improve Social Skills of Children with Autism.
- Published in:
- Journal of Autism & Developmental Disorders, 2008, v. 38, n. 5, p. 815, doi. 10.1007/s10803-007-0449-2
- By:
- Publication type:
- Article
Human papillomavirus DNA in the dermis of condyloma acuminatum.
- Published in:
- Journal of Cutaneous Pathology, 1993, v. 20, n. 5, p. 447, doi. 10.1111/j.1600-0560.1993.tb00669.x
- By:
- Publication type:
- Article
Sequelae of World War II: An Outbreak of Chronic Cutaneous Nontuberculous Mycobacterial Infection among Satowanese Islanders.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 11, p. 1541, doi. 10.1086/598928
- By:
- Publication type:
- Article
Letter from the Editors.
- Published in:
- Journal of Public & International Affairs, 2023, p. 1
- By:
- Publication type:
- Article
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2018, v. 55, n. 3, p. 379, doi. 10.1007/s12016-018-8702-3
- By:
- Publication type:
- Article
The Effect of Lebrikizumab on Inflammatory Biomarkers in Patients with Asthma.
- Published in:
- touchREVIEWS in Respiratory & Pulmonary Diseases, 2023, v. 8, n. 1, p. 2, doi. 10.17925/USRPD.2023.8.1.2
- By:
- Publication type:
- Article
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2139, doi. 10.1007/s13555-024-01219-8
- By:
- Publication type:
- Article
Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1849, doi. 10.1007/s13555-024-01183-3
- By:
- Publication type:
- Article
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1145, doi. 10.1007/s13555-024-01158-4
- By:
- Publication type:
- Article
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 4, p. 933, doi. 10.1007/s13555-024-01136-w
- By:
- Publication type:
- Article
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 12, p. 3031, doi. 10.1007/s13555-023-01054-3
- By:
- Publication type:
- Article
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 11, p. 2911, doi. 10.1007/s13555-023-01015-w
- By:
- Publication type:
- Article
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 11, p. 2499, doi. 10.1007/s13555-022-00805-y
- By:
- Publication type:
- Article
Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1431, doi. 10.1007/s13555-022-00743-9
- By:
- Publication type:
- Article
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 911, doi. 10.1007/s13555-022-00704-2
- By:
- Publication type:
- Article
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 787, doi. 10.1007/s13555-022-00687-0
- By:
- Publication type:
- Article
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 727, doi. 10.1007/s13555-022-00690-5
- By:
- Publication type:
- Article
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 701, doi. 10.1007/s13555-022-00686-1
- By:
- Publication type:
- Article
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 9, doi. 10.1007/s13555-021-00657-y
- By:
- Publication type:
- Article
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 195, doi. 10.1007/s13555-021-00643-4
- By:
- Publication type:
- Article
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 223, doi. 10.1007/s13555-021-00638-1
- By:
- Publication type:
- Article
Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2133, doi. 10.1007/s13555-021-00627-4
- By:
- Publication type:
- Article
Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 6, p. 1415, doi. 10.1007/s13555-020-00456-x
- By:
- Publication type:
- Article
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 1, p. 133, doi. 10.1007/s13555-019-00340-3
- By:
- Publication type:
- Article